SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-010092
Filing Date
2023-08-03
Accepted
2023-08-03 16:31:21
Documents
16
Period of Report
2023-07-28
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 41880
2 EX-10.1 drma_ex101.htm EX-10.1 8759
3 EX-16.1 drma_ex161.htm EX-16.1 2529
  Complete submission text file 0001654954-23-010092.txt   199113

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20230728.xsd EX-101.SCH 6017
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230728_lab.xml EX-101.LAB 16514
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230728_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230728_pre.xml EX-101.PRE 12073
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230728_def.xml EX-101.DEF 3984
10 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4986
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 231140613
SIC: 2834 Pharmaceutical Preparations